KI-nderwunsch founders: Lynae Brayboy, Felicia von Reden and Cristina Hickman (from left) from Ovom Care Ovom Care
Ovo Care is now bringing artificial intelligence into fertility treatment. This convinced several investors: the Berliners were able to raise 4.8 million euros in the seed round. The lead investor in the round is Alpha Intelligence Capital, an international investor with an AI focus. Also involved are Ananda Impact Ventures from Munich and the Berlin AI startup Merantix.
The fresh capital is intended to drive expansion in Europe. Towards the end of the year, Ovom Care’s first clinic will be opening in Lisbon, Portugal. The EU country has more liberal legislation, including in in-vitro treatment (IVF), than in Germany. The fertility startup is currently working with Avenues Fertility Clinic in London. In addition, the seed money will flow into improving the AI platform and further research.
Read too
Midjourney used for the pitch deck: Six reasons why you should do the same
Ovo Care’s AI aims to improve patient outcomes and minimize price
The Berlin startup wants to use historical and personal patient data to improve the treatment of people with fertility problems. To do this, it provides clinicians and embryologists with personalized patient data to support medical decision-making. This should also enable more dynamic pricing, including reimbursement of costs if pregnancy does not occur.
The startup, founded at the beginning of 2023, is led by CEO Felicia von Reden and the two co-founders Dr. Lynae Brayboy (COO) and Dr. Cristina Hickman (Chief Media Officer). Von Reden says she is an infertility patient. Brayboy is an embryologist and also the founder of the partner clinic Avenues in London. Hickman is a reproductive doctor and was previously chief medical officer at the fertility app Clue. She left there shortly before Ovom was founded in January 2023.
To convince their investors, the three founders also use a pitch deck, which we show you exclusively here. You can find more exciting pitch decks on this overview page.